Solid dosage form comprising a fibrate and a statin

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060068015A1
SERIAL NO

10513778

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pharmaceutical compositions in particulate form or in solid dosage forms comprising a combination of a fibrate, notably fenofibrate, and a statin (also known as a HMG CoA reductase inhibitors), which compositions are manufactured without any need of addition of water or an aqueous medium and wherein at least 80% of the active substances (i.e. the fibrate and the statin) are present in the composition in dissolved form in order to ensure suitable bioavailability of both active ingredients upon oral administration

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VELOXIS PHARMACEUTICALS A/S2970 HØRSHOLM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Holm, Per Vanlose, DK 78 963
Norling, Tomas Lyngby, DK 43 1028

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation